Platform round
Investors join the DeepTech Builder platform round, funding scouting, validation, and venture creation.
This round aligns incentives and grants early access to our entire pipeline.
We partner with investors seeking high-growth, defensible DeepTech opportunities across Europe.
DeepTech Builder sits at the intersection of academia, corporates, and capital.
We translate scientific validation into investable companies by running structured de-risking frameworks and aligning incentives through co-investment and shared outcomes.
Spain and Europe generate outstanding scientific research, yet only a small fraction becomes scalable ventures.
We source, validate, and build spinoffs with strong IP, high technical readiness, and clear pathways to commercialization — creating a portfolio of defensible DeepTech companies that systematically unlock this gap.
Our scouting engine, IP desk, fit-validation programs, and multidisciplinary network identify the best early opportunities — while our execution and governance frameworks turn validated science into scalable businesses ready for capital.
Investors join the DeepTech Builder platform round, funding scouting, validation, and venture creation.
This round aligns incentives and grants early access to our entire pipeline.
Validated technologies are formed into new companies with governance, grants, IP setup, market fit, and execution teams.
Investors can participate in subsequent rounds of the most promising companies, with DTB co-investing alongside them.
Companies scale through commercial traction, industrial partnerships, and follow-on institutional capital — creating long-term DeepTech value.
We source and validate only scientific breakthroughs with a clear path to commercialization.
Our frameworks reduce scientific, technical, market, and governance uncertainty before capital is deployed.
Aligned incentives ensure long-term value creation, improved economics, and better access to future rounds.
DeepTech cannot be evaluated like SaaS. It must be structured and managed.
We approach it through four engines:
Strong defensibility, IP position, and validated scientific basis.
Clear commercial need, industry validation, and initial customer alignment.
We build founding teams, leadership structures, and company governance adapted to DeepTech timelines.
Grant strategy, investor mapping, regulatory compliance, and staged funding pathways.
We prioritize sectors where European science is strong and where DeepTech can unlock large, defensible outcomes:
DeepTech Builder is led by founders and venture partners with decades of combined scientific, investment, and company-building experience — supported by sector and clinical advisors.